 |
Investigation Into Some Sorts of Amendments in China and Europe
|
|
2022-02-17 |
|
Hank SHEN Chinese Patent Attorney Mechanical Engineering Department Linda Liu Partners In the patent (invention or utility model) application process, in order to overcome the problems pointed out by the examiner or to obtain the desired sc |
 |
A Comparative Study on Chinese Conflicting Application System and Coping Strategies
|
|
2022-02-17 |
|
Hongjie YUE Yinhuan BAI Chinese Patent Attorney Mechanical Engineering Department Linda Liu Partners Abstract: A comparative study on Chinese conflicting application system and similar systems in the patent laws of Europe, Japan and the Uni |
 |
Acts Considered as Violation against FRAND in SEP Negotiation
|
|
2022-02-17 |
|
Linda Liu Partners IICourt Decisions In the attention-drawing cases of IWNCOMM v. Sony and Huawei v. Samsung , of which the decisions have been made this year, the Chinese court determined that the patentee did not violate FRAND terms, the |
 |
Acts Considered as Violation against FRAND in SEP Negotiation
|
|
2022-02-17 |
|
Linda Liu Partners IGuidance Documents In recent years, SEP (standard essential patent) has become a hot topic worldwide as huge commercial interests are involved. Whether an injunction can be granted in litigation concerning SEP has been u |
 |
Latest Change in Chinese Examination of Utility Model Patent
|
|
2022-02-17 |
|
Linda Liu Partners In recent years, Chinese utility model patent has attracted attention of numerous domestic and foreign applicants due to low cost, rapid granting and no strict limitations as in German and Japan. The amount of patent appl |
 |
On Invalidation of the Patent “Pharmaceutical Composition Comprising Valsartan and NEP Inhibitors” No. 201110029600.
|
|
2022-02-17 |
|
Yan WANG Chinese Patent Attorney Chemistry Biotechnology Department Linda Liu Partners On September 15, 2017, the Reexamination Board performed oral proceedings for request for invalidation No. 4W105696. This is the fifth case included in t |
 |
Preliminary Study on Determination of Equivalent Infringement in China
|
|
2022-02-17 |
|
Hank SHEN Chinese Patent Attorney Mechanical Engineering Department Linda Liu Partners The infringement of invention and utility model patents (hereinafter referred to as patents) in China includes literal infringement and equivalent infrin |
 |
Response to Office Action on Claims of Purified Product Defined by Feature of Use
|
|
2022-02-17 |
|
Ran DUAN Chinese Patent Attorney Chemistry Biotechnology Department Linda Liu Partners In some product claims, the product is defined by a feature of use. Although the limiting effect of the feature of use to the product remains disputable, |
 |
How We Should Write Claims of Biological Sequences to Get Favors from Examiners and Judges
|
|
2022-02-18 |
|
Wenhan LIU Chinese Patent Attorney Chemistry Biotechnology Department Linda Liu Partners In Chinas patent practice, people have been contending about ways of writing a claim of a biological sequence that could balance between interests of t |
 |
A Brief Analysis of the Reply to Office Actions Aimed at Claims of “Product by Process” by Briefing a Re-examination
|
|
2022-02-18 |
|
Guangping ZHANG Chinese Patent Attorney Electrical Engineering Department Linda Liu Partners I. Introduction A product claim should be defined by its own technical features as much as possible, for example, using a static structure (namely, |